SCHEMBL5200906

SCHEMBL5200906

CC(C)(O)CNc1ccc(S(=O)(=O)Oc2ccc3nc(NC(=O)C4CCNCC4)sc3c2)cc1.O=C(Nc1nc2ccc(OS(=O)(=O)c3ccc(F)cc3)cc2s1)C1CC1.O=C(Nc1nc2ccc(OS(=O)(=O)c3ccc(NC4CCCC4)cc3)cc2s1)C1CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 6/20 0.45
ENPP1 P22413 5/20 0.45
ENPP2 Q13822 3/20 0.45
CLK1 P49759 1/20 0.43
SNCA P37840 1/20 0.41
DYRK1A Q13627 1/20 0.41
RIPK1 Q13546 3/20 0.40
RIPK3 Q9Y572 3/20 0.40
NPC1 O15118 3/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4402128 0.90 DYRK1A (0.49) ENPP3ENPP1ENPP2CLK1SNCA
SCHEMBL4396704 0.87 CLK1 (0.51) ENPP3ENPP1ENPP2CLK1DYRK1A
SCHEMBL4394769 0.84 CLK1 (0.56) ENPP3ENPP1ENPP2CLK1DYRK1A
SCHEMBL4397027 0.83 ENPP3 (0.53) ENPP3ENPP1ENPP2CLK1SNCA
SCHEMBL4399622 0.82 ALDH1A1 (0.51) SNCADYRK1ANPC1ALDH1A1HPGD
Hydrochloric Acid SCHEMBL4397600 0.81 ALDH1A1 (0.51) SNCADYRK1ANPC1ALDH1A1HPGD
SCHEMBL4397038 0.81 ALDH1A1 (0.43) NPC1ALDH1A1SMN1; SMN2HSD17B10MAPT
Hydrochloric Acid SCHEMBL4397033 0.81 ALDH1A1 (0.42) NPC1ALDH1A1SMN1; SMN2HSD17B10MAPT
SCHEMBL4404654 0.80 ENPP3 (0.62) ENPP3ENPP1ENPP2CLK1NPC1
SCHEMBL4402171 0.80 ENPP3 (0.56) ENPP3ENPP1ENPP2CLK1RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745044-A2 BENZOTHIAZOLE DERIVATIVES HAVING CDK MODULATING ACTIVITY AND USE THEREOF AS ANTICANCER AGENTS Aventis Pharma S.A. (FR) 2007-01-24 EP disclosed
WO-2005097787-A2 NOVEL BENZOTHIAZOLES AND THE USE THEREOF AS MEDICAMENTS AVENTIS PHARMA S.A. (FR) 2005-10-20 WO disclosed